Clinical Trial Update: A Clinical Trial to Explore the Safety and Efficacy of Injections of Macugen When Given Every 6 Weeks in Subjects With AMD [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is being conducted to assess the safety and efficacy of pegaptanib (Macugen) injections every six weeks in people with age-related macu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Drugs mentioned

• Macugen (pegaptanib sodium)

Snippet

Sponsor: Eyetech Pharmaceuticals | Conditions: Age-Related Macular Degeneration (AMD) | Phase 4 | Status: UNKNOWN